USC reports 75 new layoffs at Keck School of Medicine
Published . Updated .
Key takeaways
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest and never sell or share it. See our privacy policy.
The notice, released on Nov. 9, includes layoffs in Keck Hospital and the Health Sciences Campus.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story.
- LLY Eli Lilly and+25.1% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story.
- JNJ Johnson & Johnson+12.1% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story.
- PFE Pfizer+5.2% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story.
- MRK Merck+3.5% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | +6.43% | +4.39% | base | after close | after close | after close | after close |
| XBI | +4.51% | +0.86% | base | after close | after close | after close | after close |
| LLY | +6.91% | +4.75% | base | after close | after close | after close | after close |
| JNJ | +7.01% | +4.30% | base | after close | after close | after close | after close |
| PFE | +4.82% | +3.23% | base | after close | after close | after close | after close |
| MRK | +11.32% | +8.02% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
USC reports 75 new layoffs at Keck School of Medicine Daily Trojan
Source: Daily Trojan
The price since 20 Nov 2026: Select Sector Spdr Tr (XLV) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Johnson & Johnson (JNJ) | three days earlier | +4.30% | final price |
| Johnson & Johnson (JNJ) | five days earlier | +7.01% | final price |
| Eli Lilly (LLY) | three days earlier | +4.75% | final price |
| Eli Lilly (LLY) | five days earlier | +6.91% | final price |
| Merck (MRK) | three days earlier | +8.02% | final price |
| Merck (MRK) | five days earlier | +11.32% | final price |
| Pfizer (PFE) | three days earlier | +3.23% | final price |
| Pfizer (PFE) | five days earlier | +4.82% | final price |
| Spdr Series Trust (XBI) | three days earlier | +0.86% | final price |
| Spdr Series Trust (XBI) | five days earlier | +4.51% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | +4.39% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | +6.43% | final price |
Congressional trades in the stocks in this story
- Rep. David J. Taylor sold Eli Lilly (LLY), worth $1,001 - $15,000 on 3 Nov 2026. That is 17 days before publication. Filed 12 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 31 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 77 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 44 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 51 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 56 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 77 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 57 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Select Sector Spdr Tr (XLV)
Companies carried with this story
- XLV Select Sector Spdr Tr
For “USC reports 75 new layoffs at Keck School of Medicine,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story
- XBI Spdr Series Trust
For “USC reports 75 new layoffs at Keck School of Medicine,” Spdr Series Trust (XBI) is linked, with no stored direction, medium confidence. Reason on file: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story
- LLY Eli Lilly
In “USC reports 75 new layoffs at Keck School of Medicine,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story
- JNJ Johnson & Johnson
In “USC reports 75 new layoffs at Keck School of Medicine,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story
- PFE Pfizer
For “USC reports 75 new layoffs at Keck School of Medicine,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 20 Nov 2026 story “USC reports 75 new layoffs at Keck School of Medicine.” Reason on file: Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “medicine” (pharma and health) in this story
How “USC reports 75 new layoffs at Keck School of Medicine” reaches Select Sector Spdr Tr (XLV)
On 20 Nov 2026, “USC reports 75 new layoffs at Keck School of Medicine” is the story that connects Select Sector Spdr Tr (XLV) to this story.
Select Sector Spdr Tr (XLV) is on the page because Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story
Spdr Series Trust (XBI) is here too. Its reason reads: SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “medicine” (pharma and health) in this story
Dates in the story, and the Select Sector Spdr Tr (XLV) price range
LLY traded between 1239.21 and 1458.90 across 20 sessions. The latest close on file is 1430.09.
How solid “USC reports 75 new layoffs at Keck School of Medicine” looks
46 out of 100
“USC reports 75 new layoffs at Keck School of Medicine” scores 46 out of 100. The score uses 1 source, and 6 linked companies.